Marketresearchnews

Wednesday, 2 September 2020

Veterinary Imaging Market Worldwide Key Players Forecasts By Revenue, Growth Rate Till 2023

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Veterinary Imaging Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

The Global Veterinary Imaging Market size is projected to touch USD 1800 Mn by 2023, exhibiting a 6.90% CAGR from 2018 to 2023 (forecast period), according to a new report published by Market Research Future (MRFR). The focus on pet health has brought veterinary imaging to the forefront. Veterinary imaging has evolved with the latest diagnostic techniques capable of detecting cysts or major issues in the nick of time. Emergence of veterinary imaging clinics, veterinary clinics, and animal care providers is expected to boost market growth over the forecast period.

Also Read : https://www.globenewswire.com/news-release/2018/08/08/1548804/0/en/Veterinary-Imaging-Market-Size-and-Share-Projected-to-Reach-USD-1800-Mn-by-2023-Market-Research-Future.html

Rise in numbers of pet owners and emergence of animal healthcare brands offering imaging equipment at cost-effective prices are factors likely to fuel market demand. Growing incidence of zoonotic diseases can act as a tailwind for the market, expanding the market potential even further. According to a report by the Maine Center for Disease Control & Prevention, three-fourths of zoonotic diseases can affect humans as well. Preventive care taken at initial stages by pet lovers coupled with government campaigns to create awareness of testing can bode well for the market in the coming years. Reimbursement schemes designed for animals can work favorably for the market as well. But the expensive nature of imaging tests can be a headwind for the market.

Top Players Overview:

Notable players in the veterinary imaging market include Esaote SpA, Medical Imaging/IMCO, Inc., Hallmarq Veterinary Imaging Ltd., Heska Corporation, Canon Inc., General Electric, BCF Technology, Ltd., Merry X-Ray, Idexx Laboratory Inc., Carestream Health, Fujifilm Holding Corporation, Diagnostic Imaging System, Inc., and others.

Partnerships are abounding in the market with industry leader Heska, a U.S. company, joining hands with Pathway Vet Alliance in 2018 to enhance offerings of veterinary care nationwide. The technology of Heska can streamline the workflow within the network of veterinary clinics owned by Pathway. Animal health charities are providing funding to expedite research and development on canine health. The results can be instrumental in providing rapid diagnosis and treatment and allaying fears of pet owners.

Veterinary Imaging Market Segmentation:

The Global Veterinary Imaging Market is segmented by product type, animal type, therapeutic area, end-user, and region. Types of products in the market include instruments, veterinary imaging reagents, and veterinary software. The instruments segment is expected to generate maximum demand owing to its accuracy and cost-effectiveness. Magnetic resonance imaging systems, computed tomography imaging systems, ultrasound imaging systems, radiography (X-ray) systems, and others are grouped in the instruments segment. Within this, the radiography segment accounted for the largest market share. But the veterinary software segment is anticipated to grow robustly over the forecast period owing to its compatibility with animal imaging devices.

Animal types which can be diagnosed include small companion animals, large animals, and others. The small companion animal segment can exhibit a strong growth rate owing to increasing adoption of pets. Demand for high-quality healthcare by pet owners is projected to bolster segment growth over the forecast period.

Therapeutic areas utilizing the benefits of veterinary imaging include neurology, cardiology, oncology, orthopedics & traumatology, and others. The orthopedics & traumatology segment is the biggest followed by cardiology. This segment can thrive owing to grievous bone injuries by farm animals as well as companion animals. Rising cases of heart problems is anticipated to spur the cardiology therapeutic segment over the forecast period. The neurology segment can also experience a significant growth spurt owing to nervous system and brain disorders.

Major end-use sectors comprise hospitals & clinics, academic institutes, and others. The hospitals & clinics segment is expected to account for a lion’s share of the market owing to being a frequent hub for imaging tests. The academic institutes segment can grow at the fastest rate thanks to increased budget provided to expedite development of diagnostic imaging techniques.

Veterinary Imaging Market Regional Overview:

Regions discussed include North America, South America, the Middle East & Africa (MEA), Asia Pacific (APAC), and Europe. The North and South America markets collectively accounted for a large share of the market in 2017. Rise in pet ownership numbers, adoption of purebreds, and disposable incomes of consumers are factors expected to constantly drive the market growth. Pet insurance in Canada and the U.S. can be a plus for these markets. The Europe market holds the second spot, followed by APAC. Investments by market giants, adoption of advanced technology, and strong pet ownership rates are playing a crucial role in fueling market growth.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/veterinary-imaging-market-2919

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

3D Printing Medical Devices Market Staggering Double Digit Cagr Till 2023

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “3D Printing Medical Devices Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

A study by Market Research Future (MRFR) reports that the Global 3D Printing Medical Devices Market is likely to witness exponential growth over the forecast period 2018 to 2023. The market is likely to expand at an approximate CAGR of 18% over the forecast period.

In dental and medical device manufacturing, 3D printing medical devices has a critical role to play. Apart from the healthcare industry, 3D printing medical devices find wide application in other sectors as well that include automotive parts, food, and household items. Several therapies also make use of the 3D printing technology which includes the formation of limb prosthetics, plastic tracheal splints, titanium alternatives for hips & jaws etc. Owing to the simplified usage of the devices and progressive technology many doctors opt for 3D printing devices before conducting surgery of any part of the body. 3D printing medical devices help in eliminating errors in such cases.

Also Read : https://www.globenewswire.com/news-release/2019/07/26/1892320/0/en/3D-Printing-Medical-Devices-Market-2019-Shows-Progressive-Expansion-at-18-CAGR-by-Top-10-Global-Players-with-Forecast-to-2023.html

Growth in the worldwide 3D Printing Medical Devices Market is likely to propel at an increasing rate owing to the progressive technology, surging government spending in healthcare sector, increasing usage of 3D printing medical devices in the healthcare sector, and the simplified process of manufacturing the 3D printing medical devices.

The cost effectiveness of the 3D printing medical device makes it popular amongst major medical device manufacturers. They use it in manufacturing prostheses, custom made knee, hip implant, and hearing aids. The 3D printing medical devices market has the potential to grow exponentially due to the constant technological upgradations taking place in the industry, fast paced customer base, investment in research and development, and growing scope for biomedical application options.

However, the high-priced printers, restricted technical skills in medical devices, biocompatibility concerns related to 3D printed medical devices, and often unfavorable reimbursement policies are likely to hinder the market growth substantially.

Key Players

The global 3D printing medical devices market has been dominated by key players such as

3T RPD Ltd.
3D Systems Corporations
Bio3D Technologies
Arcam AB
Cyfuse Medical K.K.EOS GmbHConcept
EnvisionTEC, Materialise NV
Laser GmbH
Oxford Performance Materials, Inc.
Organovo Holdings, Inc.
Prodways Group
Renishaw plc
SLM Solutions Group AG
Stratasys Ltd.

Market Segmentation

The worldwide 3D printing medical devices market has been segmented based on component, types, application, end-users, and technology.

Based on component, the global market has been segmented into materials software & services, system, 3D printer, and 3D bio printer. Software & services holds the largest share of 3D printing medical devices market in forecast period.

Based on types, the global market has been segmented into surgical instruments, surgical guides, tissue engineering product, and prosthetics & implants.

Based on application, the global market has been segmented into clinical study devices, external wearable devices, tissue engineering, and implants.

Based on end-users, the global 3D printing medical devices market has been segmented into medical, hospitals, biotech and pharma companies, surgical centers, contract research organization, and academic institutions.

Based on technology, the global market has been segmented into droplet deposition, 3D printing, laser beam melting, photopolymerization, polyjet technology, laminated object manufacturing (LOM), electron beam melting (EBM), and others.

Regional Analysis

Geographically, the global 3D Printing Medical Devices Market has been segmented into Europe, the Americas, Asia-Pacific, and the Middle East & Africa.

North America is likely to lead the global 3D printing medical devices market over the forecast period. Factors affecting the growth in this region include surging government outlay towards research and development activities and expanding demand for organ transplant surgeries in the region. Europe holds the second position in the global market. The Europe market has favorable government spending in the research and development activities. The growing prevalence of diabetes registers Asia-Pacific as one of the most lucrative markets while the Middle East & Africa records the least market share owing to the inadequate healthcare facilities available in the region.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/3d-printing-medical-devices-market-6830

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Venous Blood Collection Devices Market Staggering Double Digit Cagr Till 2023

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Venous Blood Collection Devices Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

Market Research Future (MRFR) states that the worldwide venous blood collection devices market is likely to develop at a CAGR of 9.3% over the forecast period of 2017-2023.

Market Overview

Venous blood collection devices consist of holders, needles, collection tubes, and other devices which find wide application in collecting blood samples. They extend protection against radiation and contamination apart from offering mechanical protection. The worldwide venous blood collection devices market growth has been upheld primarily by increasing demand for diagnostic services. The prevalence of global chronic diseases is expanding at an alarming pace which persuades high demand for screening services and subsequently surges the development of the worldwide venous blood collection devices market. This situation has been complemented by increasing health awareness and rising disposable income among consumers. Medical device manufacturers are endeavoring towards product improvement in order to meet the soaring demand. This has resulted in the requirement of progressive venous blood collection devices which can be used for safer blood collection. Additionally, development in product portfolio by notable medical device manufacturers have resulted in the merging of the worldwide venous blood collection devices market.

Also Read : https://www.globenewswire.com/news-release/2019/07/26/1892127/0/en/Venous-Blood-Collection-Devices-Market-Striking-a-CAGR-of-9-3-By-2023-Increasing-Disposable-Income-Has-Been-Playing-a-Key-Role-in-Influencing-the-Global-Venous-Blood-Collection-Dev.html

However, the market growth can be restricted by risks linked to pricing pressure, inferior quality product from local manufacturers, and contamination.

Competitive Analysis

The global venous blood collection devices market has been dominated by prominent players such as Narang Medical (India), Fisher Scientific (Thermo Fisher Scientific Inc.) (U.S.), Vital Diagnostice (ELITech Group) (U.S.), Allegro Medical Supplies Inc. (Scrip Products Corporation) (U.S.), Zhejiang Gongdong Medical Technology Co., Ltd. (China), Sekisui Chemical Co., Ltd. (Japan), Sarstedt AG & Co (U.S.), CDRICH (China), Hongyu Medical (China), Qiagen NV (Netherlands), Improve Medical Technology Co. Ltd. (U.S.), Bio-Rad Laboratories, Inc. (U.S), Soya Green Tec Co., Ltd. (South Korea), NIPRO Medical Corporation (Japan), Medtronic Plc (U.S.), KHB (U.S.), SanLI (Myanmar.), Greiner Bio One International GmbH (Greiner Group) (Austria), Terumo Medical Corporation (Japan), Biosigma (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Radiometer Medical ApS (Danaher Corporation/ Danrad ApS) (Denmark), F.L. Medical (Italy), Becton, Dickinson and Company (U.S), and Kabe Labortechnik GmbH (Germany).

Segmentation

The worldwide venous blood collection devices market has been segmented based on material, type, end user, and application.

By material, the worldwide venous blood collection devices market has been segmented into glass, ceramic, stainless steel, plastic, and others.

Based on type, the global venous blood collection devices market has been segmented into microfluidic system, vacuum blood collection system, micro-hematocrit tubes, needles, micro-container tubes, blood collection tubes, warming devices, and others. Other venous blood collection devices comprise blood bags and venous cannula.

Based on end user, the worldwide Venous Blood Collection Devices Market has been segmented into point of care, hospitals and clinics, diagnostic centers, blood donation centers, and others.

Based on application, the worldwide venous blood collection devices market has been segmented into intraoperative blood salvage and vein blood gas sampling. The vein blood gas sampling segment has been sub-segmented into acid-base status monitoring and diagnosis of disease.

Regional Analysis

The Americas represents the most substantial market share of the worldwide venous blood collection devices sector. Wide-ranging usage of screening methods in the developed nations, increasing healthcare spending, and rapid adoption of new medical devices drive the growth of the market in the Americas. Likewise, the promising repayment landscape in the region propels the market growth to a notable extent.

APAC market has been driven by the developed owing to the healthcare sector in the region, particularly in developing economies such as India, China, and Japan. Increased demand for safe blood assortment equipment, growth in geriatric population, and increasing inclination towards disposable items in laboratories can be considered accountable factors for the development of the APAC market.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/venous-blood-collection-devices-market-5761

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Anti-hypertensive Drugs Market Statistical Analysis In 2019 By International Top 10 Players Till 2023

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Anti-hypertensive Drugs Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

The Anti-hypertensive Drugs Market is expected to experience a moderate CAGR of 2.67% during the forecast period (2018-2023) with the valuation touching USD 41,123.2 million by the end of 2023.

An uptick in the lifestyle, triggered by jet-speed urbanization and industrialization, at times reveal a few clefts. The change takes people afar from the root which can adversely impact the body. One such is hypertension or high blood pressure. If allowed to persist longer, then it has the potential to lead to much more demanding diseases such as heart failure, stroke, peripheral vascular disease, chronic kidney disease, and others. To counter the disease, anti-hypertensive drugs have been introduced by various drug manufacturers. These drugs are primarily chemicals that can lower high blood pressure or tension and curb chances of contracting myocardial infarction or stroke.

Also Read : https://www.globenewswire.com/news-release/2019/04/11/1802463/0/en/Anti-Hypertensive-Drugs-Market-to-Exceed-USD-41-123-2-Million-by-2023-at-2-67-CAGR-Say-Market-Research-Future.html

Key Players Locking Horns:

The anti-hypertensive drugs market is densely packed with several market titans who have engaged long in strategic battles to take over the market. This has created a perfect ambience for the anti-hypertensive drugs market to move forward. Companies such as Pfizer, Inc. (U.S.), AstraZeneca (U.K.), Novartis AG (Switzerland), Daiichi Sankyo Company, Ltd. (Japan), United Therapeutics Corporation (U.S.), Sanofi S.A. (France), Johnson & Johnson Services, Inc. (U.S.), Merck KGaA (Germany), Takeda Pharmaceutical Company (Japan), Boehringer Engelheim GmbH (Germany), and Bayer AG (Germany) are impacting the market with their tactical moves.

Future Market Factors:

At present, the anti-hypertensive drugs market is substantially big and the coming days promise of a moderate growth with factors such as government initiatives and introduction of generics to back it up. Hypertension is a disease that is becoming quite common, even youths are displaying symptoms of it. This has led to initiatives undertaken by governments and NGOs across the globe to make people aware of symptoms and involve them in taking necessary measures. Several programs are getting planned to build up a robust network which integrates patients as a part of the entire setup. At the same time, the anti-hypertensive drugs market is getting traction due to the mass production of generic drugs which has lowered the cost of treatment substantially.

Segmentation:

The anti-hypertensive drugs market can be judged on the basis of several segmental analysis that convey both volume-wise and value-wise data. These segments are type, therapeutic class, and distribution channel.

Based on the type, the anti-hypertensive drugs market can be segmented into primary and secondary hypertension. As of 2017, the primary segment scored the most, a growth that was triggered by genetic factors and insulin resistance. Lifestyle changes can also be considered an elemental force in pushing the segment forward.

Based on the therapeutic class, the anti-hypertensive drugs market includes calcium blockers, ACE inhibitors, vasodilators, diuretics, renin inhibitors, beta-adrenergic blockers, ARBs, and others. The diuretics segment is expected to top the market in the coming years but the ACE inhibitors are expected to receive exponential CAGR during the forecast period.

By distribution channels, the anti-hypertensive drugs market can rely on online pharmacy, e- commerce websites & online drug stores, hospital pharmacy, retail pharmacy, and others. The retail pharmacy segment is cruising ahead with substantial market lead and prospect.

Regional Challenges:

The anti-hypertensive drugs market depends mostly on the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). Region-specific analysis of the market reveals growth pockets that can be of great benefit for market players.

Presence of several major pharmaceuticals is just one of the many factors that is contributing substantially to the growth of the North American market. Other factors such as high awareness and better medical facilities are amply backing the region’s global supreme position. Structurally, the region is way ahead of its peers which is partnering well with reimbursement policies.

Europe has drivers similar to North America. The revenue that the regional market is generating is also helping them into developing strategies for further market expansion. For the companies in this region, the APAC is fast emerging as an alluring space where they are expanding their setups to increase the profit margin.

The APAC region gains mostly from its vast population which significantly possesses one of the largest patient pools globally. At the same time, several countries in the region are leaving out their cocoon to emerge as prominent economies. This has triggered in an overhauling of the prevalent setup. Healthcare sector is in the frontline that is gaining maximum benefits of such initiatives. As a host for foreign players, the region is making strategies well to take the market forward.

Changes to Change Trends:

In a recent article of the American Journal of Physiology, researchers claimed that lower level of zinc in the body can alter kidney function and increase blood pressure. The lack of it would affect kidney’s handling of sodium which would then trigger irregularity in proteins.

Hypertension Service and Hypertension Specialty Clinic, Brigham, recently started operating by providing their patients with a Bluetooth device and instructing them to check their blood pressure twice daily. Such an initiative lowered the hypertension symptoms in maximum patients as it allows doctors to alter medications in time. The process is cost-effective and uses precious hours to save lives.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/anti-hypertensive-drugs-market-2347

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Defibrillators Pads Market - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast 2020 - 2023

Market Synopsis of Global Defibrillators Pads Market:

Key Players

Medtronic, Cardiac Science Corporation, Koninklijke Philips N.V., Boston Scientific Corporation, Stryker Corporation, Cardinal Health, Biotronik SE & Co. KG, Defibtech, LLC., and Mindray Medical are Some of the key players in the Defibrillators pads market.

Market Scenario:

Defibrillation is a procedure that involves the delivery of an electric shock to the heart which causes depolarization of the heart muscles and re-establishes normal conduction of the heart’s electrical impulse. To increase the efficacy of automated defibrillator, pads are attached to them which directly touches victim’s chest and delivers a shock to them. The gel present in the pads acts as a bonding agent and helps the AED pads to adhere firmly to the victim’s skin thus, increasing its efficacy.

Defibrillators Pads Market is expected to register a CAGR of 5% during the forecast period.

The global defibrillators pads market is majorly driven by the increasing number technical advanced devices, increasing number of regulatory approvals, rising geriatric population, abuse of alcohol, the high prevalence of cardiac diseases such as ventricular fibrillation, ventricular tachycardia, and cardiac arrhythmias, and growing penetration of key market players. Furthermore, the increasing awareness of healthcare, favorable reimbursement policies, increasing innovations in research and development of medical devices, as well as rising average income of individuals are fueling the market growth. However, factors such as high cost of defibrillators pads and complicated and costly surgical procedures involved in implantation defibrillators are likely to hamper the growth of the market. Lack of proper healthcare infrastructure, as well as awareness regarding diseases such as cardiac arrhythmia and tachycardia in middle-income countries, are major challenges to the market growth.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6098

Market Segmentation:

The global defibrillators pads market is segmented on the basis of product, age group, distribution channel, and end-user. According to products, the market is segmented into manual external, manual internal, automatic external, and others

Considering the age group, the market is segmented into pediatric defibrillator pads and adult defibrillator pads.

According to the distribution channel, the market is segmented into online pharmacy, retail pharmacy, hospital pharmacy, and others.

On account of end-user, the market is segmented into pre-hospital services, hospitals & clinics, alternate care facilities, public access market, and home healthcare services market.

Based on region the market is segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. Americas region is segmented into North America and South America. Similarly, Europe is segmented into Western Europe and Eastern Europe.

Regional Analysis:

Americas is the global leader for defibrillators pads market owing to increasing prevalence of cardiovascular diseases among adults and older population and rising more elderly population which increases the vulnerability to hypertension and obesity issues which are indirect causes of heart disease. Additionally, factors such as increasing government initiatives and funding for research, development in advanced medical treatment options, and rising demand for technologically advanced treatment are likely to enhance the growth of defibrillators pads market in the American region. For instance, according to American Heart Association, in 2014, around 31% of the deaths in the U.S. were due to cardiovascular disorders. Similarly, according to stats presented in reports published by the Centers for Disease Control and Prevention, heart disease is the most common cause of death and accounted for the death of about 366,000 people in 2015. This growing rate of cardiovascular disorders is expected to have a direct effect on the growth of the defibrillators pads market as it finds whole and sole application in cardiovascular disorders.

Europe is the second largest market and holds a healthy share in the global defibrillators pads market. The European market is expected to grow at a sturdy growth rate during the forecast period due to major driving factors like availability of advanced treatment facilities, increasing healthcare expenditure along with growing need for better healthcare infrastructure and government initiatives of healthcare reform. For instance, according to 2017 statistics presented by the European Society of Cardiology, there were more than 6 million reported new cases of cardiovascular diseases in the European Union and more than 11 million in Europe as a whole. Additionally, every year 15% of deaths in Europe occur due to cardiovascular diseases. Hence cardiovascular disease being one of the major concern in Europe contributes significantly to the market growth of this region. Additionally, Europe spent around 210 Euros in 2015 for treatment of cardiovascular disorders. This rising healthcare expenditure due to cardiovascular disorders is expected to have a positive impact on the defibrillators pads market. Developed countries such as the U.S. and the U.K. are making it compulsory for certain sports arenas, schools, government facilities, and institutes to store and maintain Automated External Defibrillators (AEDs), as unavailability of defibrillators is the most common cause of sudden cardiac arrest.

The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access and availability of treatment facilities. In the Middle East, United Arab Emirates is the largest market share owing to the development of healthcare industry and rising availability of specialty care centers.

Asia Pacific is expected to be the fastest growing market. According to report published by the United Nations in 2015; between 2015 and 2030, the number of older persons aged 60 years or over in the world is predicted to grow by 56 %, out of which 66% of the older population would reside in Asia-Pacific regions. This makes the region prone to metabolic disorders that would further aid the chances of cardiovascular diseases. Owing to the huge patient pool, a faster adaptation of healthcare technology, government initiatives to increase the healthcare quality, favorable insurance and reimbursement policies, and key players such as Boston Scientific Corporation and Medtronic have been setting up their regional headquarters and manufacturing plants in Singapore, China, Japan, Korea, and Australia. This is accelerating the growth of the defibrillators pads market. Moreover, raising adaption of western culture has led to increasing sedentary lifestyle due to work culture, addiction to alcohol and smoking, consumption of fast foods which are the indirect causes of cardiovascular diseases and rise in the standard of living in the region also contributes to defibrillators pads market growth. However, on the other hand, factor such as lack of skilled healthcare professionals may slow down the market growth during the forecast period. For instance, according to the Global Burden of Disease Report in 2016, heart diseases is expected to lead to 1.7 million deaths in India. This rising prevalence of heart diseases is expected to propel the growth of the market.

Browse More Medical Device Reports @ https://www.marketresearchfuture.com/reports/defibrillators-pads-market-6098

Coronary Stent Market Share, Global Insights And Gross Margin Analysis 2020-2023

Coronary stents are small stretchy tube-like devices used to expand the arteries of the patient in order to prevent blockage. A coronary stent is inserted into the artery of a patient suffering from a coronary disease due to the build-up of plaque. It is used for widening the narrowed arteries, and it helps in reducing chest pain and the chance of heart attack

The global coronary stent market is mainly driven by the high prevalence of heart-related diseases and huge demand for diagnosis and treatment methods. Additionally, the increasing availability of diagnostic services for coronary heart diseases also fuels the growth of the market. Moreover, favorable reimbursement policies are likely to boost the market growth.

Many private and government insurance organizations are present in developed countries. Over 50 private insurance companies are present in the U.S. The policies cover more than 75% of the cost of the devices and treatment. For instance, under the Medicare plan in the U.S., if the average cost of three stents is approximately USD 10,000, then USD 7,500 is reimbursed. Additionally, in developed countries such as the U.K., Canada, and Germany, other similar reimbursement policies are available. On the other hand, alternative treatment methods for coronary arteries disease and numerous cases of product recalls may hamper the market growth.

The global coronary stent market is expected to have a CAGR of 7.8% during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5915

Intended Audience

Medical Device Manufacturers
Medical Device Suppliers
Medical Research Laboratories
Research and Development (R&D) Companies
Market Research and Consulting Service Providers
Potential Investors

Segments

The global coronary stent market is segmented on the basis of type, mode of delivery, material, and end-user.

On the basis of type, the market is segmented into bare-metal stents, drug-eluting stents, and bio absorbable stents.

On the basis of mode of delivery, the market is segmented into balloon-expandable stents and self-expanding stents.

On the basis of material, the market is segmented into metallic stents, cobalt chromium, platinum chromium, nickel titanium, stainless steel, and others.

On the basis of end-user, the market is segmented into hospitals and clinics, cardiac centers, ambulatory surgical centers, and others.

Regional Analysis of the Global Coronary Stent Market

The American coronary stent market is segmented into two regions, namely, North America and South America. North America, being the largest market, is mainly driven by the increasing patient population suffering from coronary heart disease, growing investment in healthcare, and increasing geriatric population. Furthermore, the U.S. is the largest market in North America owing to the presence of a large number of market players manufacturing coronary stents and the increasing awareness about risk factors for the coronary heart disease. Canada is expected to be the fastest growing market which is driven by the overall increasing demand for medical devices with progress in coronary stent devices. South America is expected to be the fastest growing market due to technologically advanced devices for diagnosis and the increasing demand for treatment options of the coronary heart disease.

The European coronary stent market exhibits a positive growth with an increasing emphasis on the diagnosis of heart diseases and other related diseases. Moreover, Germany and the U.K. are the major contributors to the growth of the market. Additionally, the increasing expenditure in healthcare by major countries in Europe also accelerates the growth of the market.

Asia Pacific is expected to be the fastest growing market whose growth is attributed to the increasing burden of cardiovascular diseases and increasing focus on early diagnosis and treatment of heart diseases. Furthermore, other factors contributing to the growth of the market are lifestyle changes, the influence of western culture among adults, and addiction to smoking. Additionally, the increasing environmental pollution and exposure to harmful chemicals also attribute to the growth of the market.

The Middle Eastern and African market for coronary stents exhibits a steady rise with an increase in the number of healthcare facilities providing treatments for chronic conditions and the flourishing growth of the medical device sector especially diagnostic devices. In the African region, the awareness about the coronary heart disease is increasing the growth of the market.

Key Players in the Global Coronary Stent Market

Some of the key players in this market are BIOTRONIK SE & Co. KG (Germany), B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), Medtronic plc (Ireland), MicroPort Scientific Corporation (China), Meril Life Sciences Pvt. Ltd. (India), Vascular Concepts (India), and Translumina GmbH (Germany), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.),STENTYS SA (France), Biosensors International Group, Ltd. (Singapore), Kyoto Medical Planning Co. Ltd. (Japan), Elixir Medical Corporation (U.S.), and Reva Medical Inc. (U.S.), and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/coronary-stent-market-5915

Global Glioma Diagnosis and Treatment Market Drivers, Segmentations, Key Players, Analysis & Forecast 2020 - 2023

Market Scenario

A Glioma is a type of tumor that originates in the brain and is also known as a primary brain tumor. There are numerous types of gliomas which are entitled based on the origin of the cell type including oligodendrogliomas, astrocytoma, ependymomas, and glioblastoma. Nearly 33 percent of all brain tumors are gliomas. These originate in glial cells surrounding the neurons in the brain.

Global Glioma Diagnosis and Treatment market is expected to grow at a CAGR of approximately 10.1% during the forecast period, 2017–2023.

According to the American Brain Tumor Association, more than 79,000 new cases of primary brain tumors were diagnosed in 2017 with 24.7% of those being gliomas.

Brain tumors are one of the prominent causes of cancer among children and teenagers. Glioma is the most common type of brain tumor which accounts for approximately half of all the astrocytoma. The increasing occurrence of glioblastoma over the years is responsible for the growth of the glioma diagnosis and treatment market. The upcoming drug launches and developments in research are instrumental for the growth of the market. In addition, the current unmet need is expected to drive the gliomas industry over the forecast period. Changing financial demands and access to healthcare facilities are some of the factors that are constraining the market growth.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5877

Astrocytoma is the most common types of glioma diagnosed worldwide, as more than 30% of all the diagnosed cases with brain tumors are astrocytoma. These types of tumors are not curable as they spread easily through normal brain tissue. The American Brain Tumor Association has evaluated that around 7% of all the primary brain tumors represent astrocytoma.

The expanding market for the treatment of brain cancer-associated symptoms, the increasing prevalence of brain cancer, and innovations in drug delivery to brain cancer cells are some of the key factors augmenting the demand in the global glioma diagnosis and treatment market. Furthermore, the introduction of novel therapies coupled with various organizations generating awareness and increasing geriatric population are factors driving the growth of the global glioma diagnosis and treatment market.

Key Players

Some of the key players in the global glioma diagnosis and treatment market are Thermo Fisher Scientific Inc. (U.S.), Emcure Pharmaceuticals Ltd. (India), Sigma-Aldrich Co. (U.S.), Pfizer Inc. (U.S.), Taj Pharmaceuticals Limited (India), Novartis International AG (Switzerland), Teva Pharmaceutical Industries Ltd. (Israel), GE Healthcare (U.S.), Siemens Healthineers (U.S.), Philips Healthcare (U.S.), Shimadzu Corporation (Japan), Toshiba Medical Systems Corporation (Japan), Merck & Co., Inc. (U.S.), F. Hoffmann-Le Roche AG (Switerland), Arbor Pharmaceuticals, LLC (U.S.), Sun Pharmaceutical Industries, Ltd. (India), Amneal Pharmaceuticals. LLC (U.S.), AstraZeneca (UK), Carestream Health (U.S.), Hitachi Medical Corporation (U.S.), and others.

Segmentation

Geographically, the Americas glioma diagnosis and treatment market is segmented into two major regions, namely, North America and South America.

North America accounted for the largest share of the global gliomas industry in 2016, and the trend is expected to continue over the projected period. Moreover, it is anticipated that about 80,000 new cases will be registered related to brain tumors in the year 2017 which includes 26,000 primary malignant brain tumors.

The Americas glioma diagnosis and treatment market is segmented on the basis of type, diagnosis, treatment, grade, location, and end-user.

Regional Analysis

The global glioma diagnosis and treatment market consist of four major regions, namely, the Americas, Europe, Asia Pacific, and the Middle East and Africa.

Growing medical tourism and prevalence of metastatic tumors that require surgical procedures are favoring the growth of the market in the Middle East and Africa. In addition, the development of drug delivery technologies, a combination of modern diagnostic techniques, and increasing awareness of various types of brain tumors are similarly supporting the growth of this market.

The Americas dominates the market owing to the key players domiciled in these regions coupled with the increasing incidences of brain tumor, rising awareness among people, and increasing healthcare expenditure. Brain tumor is the third most common types of cancer in adults in North America. According to the North American Brain Tumor Coalition over 44,500 people in the U.S. were diagnosed with a primary tumor in the brain in 2014. Thus, the increasing incidences of primary brain tumor support the growth of the malignant glioma treatment in North America.

Asia Pacific is estimated to be the most lucrative market for gliomas due to the increasing occurrence of brain tumors in Asia Pacific countries such as China and others. The growth in the Asian market is fueled by the expanding healthcare infrastructure and presence of untapped market opportunities in this region. This region is considered as an emerging market owing to the increasing number of manufacturers coupled with the increasing market penetration.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/glioma-diagnosis-treatment-market-5877